Skip to main content
Log in

The immunologic and immunotherapeutic sequelae of intraperitoneal BCG

I: The local nature of immunostimulation and the effects of delayed-type hypersensitivity

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Summary

BCG administered intraperitoneally (IP) was shown to have an immunoprophylactic effect against an ascites tumour. The dosage used was shown to have no immunosuppressive effects, as measured by subcutaneous tumour growth and delayed type hypersensitivity (DTH). In C57BL mice BCG was found to enhance DTH, in contrast with previous immunogenetic studies. The relationship between previously reported BCG-induced immunosuppression and immunotherapy is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bailey, N. T. J. 1981. Statistical Methods in Biology. 2nd Edition. Hodder and Stoughton, London, up. 49.

    Google Scholar 

  • Barker, C. F. and Billingham, R. E. 1977. Immunologically privileged sites. Adv. Immunol. 25, 1.

    Article  PubMed  CAS  Google Scholar 

  • Boyle, W. 1968. An extension of the51Cr-release assay for the estimation of mouse cytotoxins. Transplantation 6, 761.

    Article  PubMed  CAS  Google Scholar 

  • Brazil, J. 1976. M.Sc. thesis, National University of Ireland’, p. 64.

  • Chee, D. O. and Bodurtha, A. J. 1974. Facilitation and inhibition of B16 melanoma by BCGin vivo and by lymphoid cells from BCG treated micein vitro. Int. J. Cancer 14, 137.

    Article  PubMed  CAS  Google Scholar 

  • Corsini, A. C., Bellucci, S. B. and Costa, M. G. 1979. A simple method of evaluating delayed type hypersensitivity in mice. J. Immunol. Methods 30, 195.

    Article  PubMed  CAS  Google Scholar 

  • Currie, G. A. and Bagshawe, K. D. 1968. The role of sialic acid in antigen expression: further studies of the Landschutz ascites tumour. Br. J. Cancer 22, 843.

    PubMed  CAS  Google Scholar 

  • Florentin, I., Huchet, R., Bruly-Rosset, M., Halle-Dannenko, O. and Mathe, G. 1976. Studies on the mechanisms of action of BCG. Cancer Immunol. Immunother. 1, 31.

    Google Scholar 

  • Gray, J. D., Brooks, C. G. and Baldwin, R. W. 1981. Detection of eithfr rapidly cytolytic macrophages of NK cells in ‘activated’ peritoneal exudate depends in the method of analysis and the target cell type. Immunology 42, 561.

    PubMed  CAS  Google Scholar 

  • Kaledin, V. I., Kurunov, Y. N., Matienko, N.A., Nikolin, V. P. 1978. Stimulation of tumour growth in mice by high doses of BCG. J. Natl. Cancer Inst. 61, 1393.

    PubMed  CAS  Google Scholar 

  • Kato, K., Yamamoto, K., Kakinuma, M., Ishihara, C. and Azuma, I. 1981. Suppression of BCG cell wall induced delayed-type hypersensitivity by pre-treatment. I. Induction of adherent suppressor cell by live BCG injection and their characterization. Immunology 42, 259.

    PubMed  CAS  Google Scholar 

  • Klimpel, G.R. and Henney, C. S. 1978. BCG induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generationin vitro. J. Immunol. 120, 563.

    PubMed  CAS  Google Scholar 

  • Miller, T. E., Mackaness, G. B. and Lagrange, P. H. 1973. Immunopotentiation with BCG, II. Modulation of the response to sheep red blood cells. J. Natl. Cancer Inst. 51, 1669.

    PubMed  CAS  Google Scholar 

  • Morton, D. L., Eilber, F. R., Malmgren, R. A. and Wood, W. C. 1970. Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68, 158.

    PubMed  CAS  Google Scholar 

  • Nelson, D. S., Nelson, M. and Hopper, K. E. 1980. Mechanism of resistance of mice to syngeneic methylcholanthrene induced fibrosarcomas. Adv. Exp. Med. Biol. 12113, 541.

    Google Scholar 

  • PPeto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, DD R., Howard, S. V., Mantel, N., McPherson, K., Peto, J. and Smith, P. G. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient (II Analysis and Examples). Br. J. Cancer 35, 1.

    PubMed  CAS  Google Scholar 

  • Prehn, R. T. and Main, J. M. 1957. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18, 769.

    PubMed  CAS  Google Scholar 

  • Prehn, R. T. 1972. The immune reaction as a stimulator of tumour growth. Science 176, 170.

    Article  PubMed  CAS  Google Scholar 

  • Ruckdeschel, J. C., McKneally, M. F., Baxter, D. H., De Vore, C., Kellar, S., Killam, D., Caradonna, R., Sedransk, N., Mcllduff, J. B. and Horton, J. 1981. Regional immunotherapy has a detrimental effect on the response to combined irradiation and chemotherapy in locally advanced; non-small cell bronchogenic carcinoma. Cancer Immunol. Immunother. 11, 277.

    Article  Google Scholar 

  • Schrier, D. J. Sternick, J. L., Allen, E. M. and Moore, V. L. 1981. Genetic basis of BCG-induced suppression of delayed hypersensitivity. Nature 289, 405.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roche, W.R., McLaughlin, H. The immunologic and immunotherapeutic sequelae of intraperitoneal BCG. I.J.M.S. 152, 303–306 (1983). https://doi.org/10.1007/BF02945302

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02945302

Keywords

Navigation